+6,897.8%
BNY vs GSK
+1,644.3%
+5,253.5%
-64.7%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.5% | -0.1% | -2.4% | -2.4% |
| 7D | -7.9% | -5.3% | -2.6% | -5.8% |
| 30D | -2.7% | -3.7% | +0.9% | -1.4% |
| 3M | -9.8% | -7.3% | -2.5% | -7.3% |
| 6M | +3.8% | -4.2% | +8.1% | +4.8% |
| YTD | +23.8% | +0.9% | +23.0% | +21.4% |
| 1Y | +35.0% | +7.3% | +27.7% | +28.9% |
| 3Y | +220.9% | +52.7% | +168.1% | +154.4% |
| 5Y | +183.3% | +40.1% | +143.2% | +129.0% |
| 10Y | +284.5% | +98.7% | +185.8% | +161.9% |
| All | +6,897.8% | +1,644.3% | +5,253.5% | +2,377.5% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling